Melanoma and Mastocytosis

  • Aleksandra Vojvodic Department of Dermatology and Venereology, Military Medical Academy, Belgrade, Serbia
  • Tatjana Vlaskovic-Jovicevic Clinic for Mental Disorders “Dr Laza Lazarevic” Belgrade, Serbia
  • Petar Vojvodic Clinic for Psychiatric Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Jovana Vojvodic Clinic for Mental Disorders “Dr Laza Lazarevic” Belgrade, Serbia
  • Mohamad Goldust Guglielmo Marconi University, Rome, Italy
  • Zorica Peric-Hajzler Military Medical Academy, Belgrade, Serbia
  • Dusica Matovic Military Medical Academy, Belgrade, Serbia
  • Goran Sijan Clinic for Plastic Surgery and Burns, Military Medical Academy, Belgrade, Serbia
  • Nenad Stepic Clinic for Plastic Surgery and Burns, Military Medical Academy, Belgrade, Serbia
  • Uwe Wollina Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Dresden, Germany
  • Massimo Fioranelli Department of Nuclear Physics, sub-nuclear and radiation, G. Marconi University, Rome, Italy
  • Van Thuong Nguyen Vietnam National Hospital of Dermatology and Venereology, Hanoi, Vietnam
  • Michael Tirant G. Marconi University, Rome, Italy
  • Torello Lotti University of Rome G. Marconi, Rome, Italia
Keywords: Melanoma, mastocytosis, growth factor, mastocytoma

Abstract

There are numerous cases reports and studies confirming the enhanced incidence of melanoma among patients with mastocytosis, especially with systemic mastocytosis. These two diseases are arising from two different types of cells; melanoma arises from neural crest cells and mastocytosis from hematopoietic stem cells. But there are a lot of similarities between the two diseases. The most important and significant is the dependence of the growth factor receptor câ€KIT and câ€KIT ligand (stem cell factor) for their growth and development. Also, expression of the STAT3 (signal transducer and activator of transcription 3) and transcription factors MITF (microphthalmiaâ€associated transcription factor) make the connection between melanoma and mastocytosis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

Author Biography

Torello Lotti, University of Rome G. Marconi, Rome, Italia

Prof. Lotti is Full Professor of the Dermatology and Venereology at University of Studies Guglielmo Marconi, Rome, Italy. He is Honorary Professor of Dermatology - China Medical University Shenyang (2011), Lecturer at the New York Academy of Sciences "Howard Fox Memorial Lecture" (14 March 2012 - New York, NY – USA), and Chair, Executive Scientific Committee Vitiligo Research Foundation, New York , NY , USA. He is President of the World Health Academy, Dermatology since 2013. He has been Full Professor of the Dermatology and Venereology Division at University of Florence School of Medicine, Florence, Italy, from 2006 to 2010. He is Visiting Professor in six International Universities worldwide, and Key Note Lecturer in several international dermatology Societies. His activities in serving Dermatology have been numerous: President of the Italian Society of Dermatology and Venereology (SIDeMaST , 2009-2010) and President of the International Society of Dermatology ( ISD, 2009-2010), President of the European Society for Cosmetic and Aesthetic Dermatology (2003-2004), Editor in Chief of the Journal of the European Academy of Dermatology and Venereology (1992-2002) , Editor "Therapeutic Hotline"- Dermatologic Therapy (2007-)and served as Editor in Chief of the Giornale Italiano di Dermatologia in the period of presidency of the Societa' Italiana di Dermatologia (2009-2010). He has been President of numerous international congresses and is currently Editor in Chief of the Giornale Italiano di Dermatologia e Venereologia ( 2010-2020 ). He is Ordinary Member of the main Scientific Societies worldwide (EADV, SIDEV , ESDR , ISD, AAD, SID) and Honorary Member of several Scientific Societies of the Dermatology field. Moreover, he is a Scientific reviewer of ten sectorial journals, among which are the British Journal of Dermatology, Journal of Investigative Dermatology, Journal of the American Academy of Dermatology , Dermatologic Therapy. He has authored 1054 scientific publications (393 peer reviewed articles, 288 books chapters e 365 abstracts). For more information, see www.torellolotti.it

References

Capo A, Goteri G, Mozzicafreddo G, Serresi S, Giacchetti A. Melanoma and mastocytosis: is really only a coincidence? Clin Exp Dermatol. 2019; 44(1):76-7. https://doi.org/10.1111/ced.13717 PMid:30178486

Molderings GJ, Zienkiewicz T, Homann J, Menzen M, Afrin LB.Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA. F1000Res. 2017; 6:1889. https://doi.org/10.12688/f1000research.12730.1 PMid:29225779 PMCid:PMC5710302

Broesby-Olsen S et al. Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study. Am J Hematol. 2016; 91(11):1069-75. https://doi.org/10.1002/ajh.24490 PMid:27428296

Phung B, et al. KITD816V Induces SRC-Mediated Tyrosine Phosphorylation of MITF and Altered Transcription Program in Melanoma. Mol Cancer Res. 2017; 15(9):1265-1274. https://doi.org/10.1158/1541-7786.MCR-17-0149 PMid:28584020

Hägglund H, Sander B, Ahmadi A, Gülen T, Nilsson G. Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis.Med Oncol. 2014; 31(8):123. https://doi.org/10.1007/s12032-014-0123-4 PMid:25034364

Abbaspour Babaei M, Kamalidehghan B, Saleem M, Huri HZ, Ahmadipour F Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells. Drug Des Devel Ther. 2016; 10:2443-59. https://doi.org/10.2147/DDDT.S89114 PMid:27536065 PMCid:PMC4975146

Ehara Y, Yoshida Y, Tahira M, Yamamoto O. The expression of melanoma inhibitory activity on mast cells in child patients with cutaneous mastocytosis. Yonago Acta Med. 2014; 57(3):99-101.

Heldin CH, Lennartsson J Structural and functional properties of platelet-derived growth factor and stem cell factor receptors. Cold Spring Harb Perspect Biol. 2013; 5(8):a009100. https://doi.org/10.1101/cshperspect.a009100 PMid:23906712 PMCid:PMC3721287

Donati P, Paolino G, Donati M, Panetta C. Cutaneous mastocytosis combined with eruptive melanocytic nevi and melanoma. Coincidence or a linkage in the pathogenesis? J Dermatol Case Rep. 2014; 8(3):70-4. https://doi.org/10.3315/jdcr.2014.1179 PMid:25324908 PMCid:PMC4195503

Published
2019-08-30
How to Cite
1.
Vojvodic A, Vlaskovic-Jovicevic T, Vojvodic P, Vojvodic J, Goldust M, Peric-Hajzler Z, Matovic D, Sijan G, Stepic N, Wollina U, Fioranelli M, Nguyen VT, Tirant M, Lotti T. Melanoma and Mastocytosis. Open Access Maced J Med Sci [Internet]. 2019Aug.30 [cited 2020Oct.20];7(18):3050-2. Available from: https://www.id-press.eu/mjms/article/view/oamjms.2019.772

Most read articles by the same author(s)

1 2 3 > >>